Cancer Treatment market research reports by DelveInsight

• Metastatic triple-negative breast cancer (mTNBC) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Metastatic triple-negative breast cancer (mTNBC) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Metastatic triple-negative breast cancer (mTNBC) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Metastatic trip ... Read More

• Throat Cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Throat Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Throat Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Throat Cancer, historical and forecasted epidemiology as well as the Throat Cancer ma ... Read More

• Thyroid Cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Thyroid Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Thyroid Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Thyroid Cancer, historical and forecasted epidemiology as well as the Thyroid Cance ... Read More

• Adenoid Cystic Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Adenoid Cystic Carcinoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Adenoid Cystic Carcinoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Adenoid Cystic Carcinoma, historical and forecasted epidemiolog ... Read More

• Adult T-Cell Leukemia-Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Adult T-Cell Leukemia-Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Adult T-Cell Leukemia-Lymphoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Adult T-Cell Leukemia-Lymphoma, historical and fore ... Read More

• Advanced Renal Cell Carcinoma (RCC) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Advanced Renal Cell Carcinoma (RCC) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Advanced Renal Cell Carcinoma (RCC) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Advanced Renal Cell Carcinoma (RCC), hist ... Read More

• Bile Duct Cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Bile Duct Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Bile Duct Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Bile Duct Cancer, historical and forecasted epidemiology as well as the Bile Du ... Read More

• BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the BRAF Mutated Non- ... Read More

• Human Papillomavirus-positive Oropharyngeal Cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Human Papillomavirus-positive Oropharyngeal Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Human Papillomavirus-positive Oropharyngeal Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Human Papil ... Read More

• Uterine Sarcoma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Uterine Sarcoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Uterine Sarcoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Uterine Sarcoma, historical and forecasted epidemiology as well as the Uterine Sa ... Read More

• Gallbladder Cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Gallbladder Cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Gallbladder Cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Gallbladder Cancer, historical and forecasted epidemiology as well as the G ... Read More

• Lymphedema – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Lymphedema – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Lymphedema – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Lymphedema, historical and forecasted epidemiology as well as the Lymphedema market trends ... Read More

• Testicular cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Testicular cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Testicular cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Testicular cancer, historical and forecasted epidemiology as well as the Test ... Read More

• BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""BRAF-Mutant Metastatic Melanoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the BRAF-Mutant Metastatic Melanoma, historical and f ... Read More

• CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Multiple Myeloma pipeline landscape. It cover ... Read More

• Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

• Unresectable Melanoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Unresectable Melanoma - Pipeline Insight, 2024 Unresectable Melanoma Overview ""Unresectable Melanoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Unresectable Melanoma market. A detailed pictu ... Read More

• Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 Acute Lymphoblastic Leukemia (ALL) Overview ""Acute Lymphoblastic Leukemia (ALL) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute L ... Read More

• Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Attributed to the rising diagnosed prevalent cases and increasing awareness, the Molybdenum Cofactor Deficiency Type A (MoCoD-A) market was valued at nearly USD 12 million in 2023 and is expected to exp ... Read More

• Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024 Adult T-Cell Leukemia-Lymphoma Overview ""Adult T-Cell Leukemia-Lymphoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adult T-Cell Leukem ... Read More

• Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024 Advanced Breast Cancer in Premenopausal Women Overview ""Advanced Breast Cancer in Premenopausal Women Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and gr ... Read More

• Advanced Pancreatic Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Advanced Pancreatic Cancer - Pipeline Insight, 2024 Advanced Pancreatic Cancer Overview ""Advanced Pancreatic Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Advanced Pancreatic Cancer mark ... Read More

• Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. I ... Read More

• Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline ... Read More

< prev 2 3 4 5 6 7 8 9 10 11 next >